“…Increasing numbers of studies have reported on restricted TCR ~ usage in various diseases, such as experimental allergic encephalomyelitis [1,42], allograft rejection [6,23], multiple sclerosis [29], Grave's disease [11,38], sarcoidosis [26], primary biliary cirrhosis [25], Crohn's disease [31] and choriomeningitis [41]. It is also well known that TCR V gene usage is restricted in human T cells stimulated with superantigen [8,20] as well as in TIL of melanoma and glial tumours [27,28].…”